State Street Corporation 13D and 13G filings for Halozyme Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 11:18 am Sale | 2025-03-31 | 13G | Halozyme Therapeutics, Inc. HALO | STATE STREET CORP STT | 6,053,007 4.900% | -582,820 (-8.78%) | Filing |
| 2024-10-17 09:36 am Purchase | 2024-09-30 | 13G | Halozyme Therapeutics, Inc. HALO | STATE STREET CORP STT | 6,635,827 5.200% | 6,635,827 (New Position) | Filing |